Aagam Shah

Aagam Shah

Principal atSands Capital VenturesVirginia

Aagam Shah is a principal at Sands Capital Ventures focusing on therapeutic investments. He joined the firm in 2022 and was promoted to principal in 2025.

What Aagam can write

Writes checks of$10M to $30M
Comes in atSeries A, Series BMostly follows a lead
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Sands Capital Ventures writes $10M to $30M checks, larger than 97% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Sands Capital Ventures.

Career

  1. Massachusetts Institute of Technology · Research Support Associate III
    2014-2015
  2. ETH Zurich · Graduate Research Assistant
    2014-2020
  3. OCCIDENT Group AG · Investment Analyst – Life Sciences
    2021-2022
  4. Sands Capital · Associate
    Now
  5. Sands Capital · Sr. Associate
    Now
  6. OCCIDENT · worked
  7. Sands Capital · principal
    Now

Focus

therapeutic investmentslife sciences

Education

University of Mumbai, BEJohns Hopkins University, MSEETH Zurich, PhD

Also at Sands Capital Ventures

Partners like Aagam

At firms with a similar stage, sector and check size.

Alert me when Sands Capital Ventures is active

One email when Aagam's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Aagam Shah?

Aagam Shah is a principal at Sands Capital Ventures focusing on therapeutic investments. He joined the firm in 2022 and was promoted to principal in 2025.

How much does Aagam Shah invest?

Aagam Shah invests through Sands Capital Ventures, which writes checks of $10M to $30M at series a, series b.

How do I pitch Aagam Shah?

A warm intro from a founder Sands Capital Ventures backed works best.

What did Aagam Shah do before Sands Capital Ventures?

Research Support Associate III at Massachusetts Institute of Technology; Graduate Research Assistant at ETH Zurich; Investment Analyst – Life Sciences at OCCIDENT Group AG; worked at OCCIDENT.

Last updated 2026-10-15. Is this you? Ask for a correction.